371 related articles for article (PubMed ID: 25421247)
1. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Int J Mol Sci; 2014 Nov; 15(11):21554-86. PubMed ID: 25421247
[TBL] [Abstract][Full Text] [Related]
2. Aggressive infantile embryonal tumors.
MacDonald TJ
J Child Neurol; 2008 Oct; 23(10):1195-204. PubMed ID: 18952586
[TBL] [Abstract][Full Text] [Related]
3. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
4. Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.
Kamenova M; Kaneva R; Genova K; Gabrovsky N
Adv Exp Med Biol; 2023; 1405():225-252. PubMed ID: 37452940
[TBL] [Abstract][Full Text] [Related]
5. Significance and therapeutic value of miRNAs in embryonal neural tumors.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Molecules; 2014 May; 19(5):5821-62. PubMed ID: 24806581
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.
Hsieh TH; Chien CL; Lee YH; Lin CI; Hsieh JY; Chao ME; Liu DJ; Chu SS; Chen W; Lin SC; Ho DM; Liu RS; Lin CH; Wong TT; Wang HW
Carcinogenesis; 2014 Oct; 35(10):2164-74. PubMed ID: 24832085
[TBL] [Abstract][Full Text] [Related]
7. Embryonal tumors in the WHO CNS5 classification: A Review.
Gianno F; Miele E; Antonelli M; Giangaspero F
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
[TBL] [Abstract][Full Text] [Related]
8. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
9. Mouse models of CNS embryonal tumors.
Momota H; Holland EC
Brain Tumor Pathol; 2009; 26(2):43-50. PubMed ID: 19856214
[TBL] [Abstract][Full Text] [Related]
10. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.
Shih RY; Koeller KK
Radiographics; 2018; 38(2):525-541. PubMed ID: 29528832
[TBL] [Abstract][Full Text] [Related]
11. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.
MacDonald TJ; Rood BR; Santi MR; Vezina G; Bingaman K; Cogen PH; Packer RJ
Oncologist; 2003; 8(2):174-86. PubMed ID: 12697942
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.
Braoudaki M; Lambrou GI
J Hematol Oncol; 2015 Feb; 8():6. PubMed ID: 25652781
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
14. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
Cole BL; Pierson CR
Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics and Regression Analyses Manifest Tumor-Specific miRNA Expression Dynamics in Pediatric Embryonal Malignancies.
Braoudaki M; Koutsouris DD; Kouris I; Paidi A; Koutsouri G; George Lambrou I
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5834-5837. PubMed ID: 30441662
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in embryonal tumours of the central nervous system.
Sarkar C; Deb P; Sharma MC
Childs Nerv Syst; 2005 Apr; 21(4):272-93. PubMed ID: 15682321
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnostics of CNS embryonal tumors.
Pfister SM; Korshunov A; Kool M; Hasselblatt M; Eberhart C; Taylor MD
Acta Neuropathol; 2010 Nov; 120(5):553-66. PubMed ID: 20882288
[TBL] [Abstract][Full Text] [Related]
18. Genomic Molecular Classification of CNS Malignancies.
Spino M; Snuderl M
Adv Anat Pathol; 2020 Jan; 27(1):44-50. PubMed ID: 31714292
[TBL] [Abstract][Full Text] [Related]
19. DNMTs as potential therapeutic targets in high-risk pediatric embryonal brain tumors.
Sin-Chan P; Huang A
Expert Opin Ther Targets; 2014 Oct; 18(10):1103-7. PubMed ID: 25142793
[TBL] [Abstract][Full Text] [Related]
20. Embryonal Tumors of the Central Nervous System: The WHO 2016 Classification and New Insights.
Pinheiro JAF; de Almeida JCM; Lopes JMPB
J Pediatr Hematol Oncol; 2021 Apr; 43(3):79-89. PubMed ID: 32925406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
